Clincosm LogoSign in Get a demo

A Study to Compare CSF Flow Metrics Across Platforms

Sponsor
Mayo Clinic (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05221918
Collaborator
(none)
15
Enrollment
1
Location
6
Anticipated Duration (Months)
2.5
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of this research is to find out more about detecting movement of CSF (fluid around the brain) with MRI. Researchers are doing this research study to find out how measurements of CSF movement differ among MRI machines and how image quality is changed by reducing the scan time.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    15 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Comparison of CSF Flow Metrics Across MRI Platforms
    Anticipated Study Start Date :
    Aug 1, 2022
    Anticipated Primary Completion Date :
    Feb 1, 2023
    Anticipated Study Completion Date :
    Feb 1, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Comparison of flow metrics among scanners [February -December 2022]

      Flow metrics such as average total flow will be compared among multiple MRI scanners

    2. Comparison of flow metrics between scans with and without parallel imaging [February -December 2022]

      Flow metrics such as the average total flow will be compared between sequences acquired with and without acceleration techniques, including parallel imaging, for a given scanner

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 40 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • A healthy volunteer will be defined as an otherwise healthy person who does not have a medical condition that affects brain function or have problems with concentration, memory, balance, or coordination.
    Exclusion Criteria:
    • Subjects with non-MRI compatible devices, required sedation (claustrophobia or unable to remain still for exam), or women who are pregnant will be excluded.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Mayo Clinic Rochester Minnesota United States 55905

    Sponsors and Collaborators

    • Mayo Clinic

    Investigators

    • Principal Investigator: Petrice Cogswell, MD, PhD, Mayo Clinic

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Petrice M. Cogswell, Principal Investigator, Mayo Clinic
    ClinicalTrials.gov Identifier:
    NCT05221918
    Other Study ID Numbers:
    • 21-002907
    First Posted:
    Feb 3, 2022
    Last Update Posted:
    Jun 24, 2022
    Last Verified:
    Jun 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Jun 24, 2022